Publications and Further Research Outputs
Peer-Reviewed Publications
Fiona O"Connell, Eimear Mylod, Noel E. Donlon, Maria Davern, Christine Butler, Niamh O"Connor, Meghana Menon, Claire L. Donohoe, Narayanasamy Ravi, Derek G. Doherty, Margaret R. Dunne, John V. Reynolds, Helen M. Roche, Jacintha O"Sullivan, Adipose tissue from oesophageal adenocarcinoma patients is differentially affected by chemotherapy and chemoradiotherapy regimens altering immune cell phenotype and cancer cell metabolism, Translational Oncology, 53, 2025, p102302 - 102302, p102302-102302
Tao Zhang, Kit Chan, Abdulilah ECE, Robin Daly, Aoife Cannon, Neil Frankish, Jacintha O'Sullivan, Padraig Fallon, Helen Sheridan, Bioactive Indanes: Design, Synthesis and Bioactivity Investigation of 2,2-Substituted Indane Derivatives, a New Bioactive Indane Scaffold, Bioorganic Chemistry, 2025
R Corcoran, Finbarr O"Connell, N Schellenberg, Jacintha O"Sullivan, David Kevans, P0084 Secreted inflammatory protein profiles of human inflammatory bowel disease explants following treatment ex-vivo with licenced biologic therapies and patients" in-vivo response, Journal of Crohn s and Colitis, 19, (Supplement_1), 2025, pi449 - i449, pi449-i449
Sharma, S., Carey, N., McConnell, D. Lowery, M., O'Sulliavan, J., McCullagh, L. for the HEALED Consortium, Systematic Review of Economic Evaluations of Systemic Treatments for Advanced and Metastatic Gastric Cancer, PharmacoEconomics, 2024
Bennett, A.E., O'Neill, L., Doyle, S.L., Guinan, E.M., O'Sullivan, J., Reynolds, J.V., Hussey, J., Nutrient Intakes and Gastrointestinal Symptoms Among Esophagogastric Cancer Survivors up to 5 Years Post-Surgery, Nutrition and Cancer, 2024, p1-10
Oâ Sullivan, Niall J. and Temperley, Hugo C. and Kyle, Eimear T. and Sweeney, Kevin J. and Oâ Neill, Maeve and Gilham, Charles and Oâ Sullivan, Jacintha and Oâ Kane, Grainne and Mehigan, Brian and Oâ Toole, Sharon and Larkin, John and Gallagher, David and McCormick, Paul and Kelly, Michael E., Assessing circulating tumour DNA (ctDNA) as a prognostic biomarker in locally advanced rectal cancer: a systematic review and meta-analysis, International Journal of Colorectal Disease, 39, (1), 2024
Kathleen A. J. Mitchelson, Fiona O"Connell, Jacintha O"Sullivan, Helen M. Roche, Obesity, Dietary Fats, and Gastrointestinal Cancer Risk-Potential Mechanisms Relating to Lipid Metabolism and Inflammation, Metabolites, 14, (1), 2024, p42 - 42, p42-42
C McShane, Fiona O"Connell, R Corcoran, Croí E. Buckley, Niamh Lynam"Lennon, David Kevans, Jacintha O"Sullivan, P066 Serum amyloid A " A Novel Biomarker of Ulcerative Colitis Disease Activity, Journal of Crohn s and Colitis, 18, (Supplement_1), 2024, pi336 - i336, pi336-i336
Murphy DM, Walsh A, Stein L, Petrasca A, Cox DJ, Brown K, Duffin E, Jameson G, Connolly SA, O'Connell F, O'Sullivan J, Basdeo SA, Keane J, Phelan JJ., Human Macrophages Activate Bystander Neutrophils' Metabolism and Effector Functions When Challenged with Mycobacterium tuberculosis., International journal of molecular sciences, 25, (5), 2024, p2898
Laura Kane, Brian Flood, Joan Manils, Donna E McSkeane, Aoife P. Smith, Miriam Tosetto, Fatema Alalawi, Joanna Fay, Elaine W. Kay, Cara Dunne, Stephen McQuaid, Maurice B. Loughrey, Jacintha O"Sullivan, Elizabeth J. Ryan, Kieran Sheahan, Glen Doherty, Emma M. Creagh, Caspase-4 has potential utility as a colorectal tissue biomarker for dysplasia and early-stage cancer, Gastro Hep Advances, 4, (2), 2024, p100552 - 100552, p100552-100552
O'Brien, R.M. and Meltzer, S. and Buckley, C.E. and Heeran, A.B. and Nugent, T.S. and Donlon, N.E. and Reynolds, J.V. and Ree, A.H. and Redalen, K.R. and Hafeez, A. and O'RÃordáin, D.S. and Hannon, R.A. and Neary, P. and Kalbassi, R. and Mehigan, B.J. and McCormick, P.H. and Dunne, C. and Kelly, M.E. and Larkin, J.O. and O'Sullivan, J. and Lysaght, J. and Lynam-Lennon, N., Complement is increased in treatment resistant rectal cancer and modulates radioresistance, Cancer Letters, 604, (217253), 2024
Simone Marcone, Jolanda Spadavecchia, Memona Khan, Gabriele Vella, Fiona O"Connell, Marzia Pendino, Meghana Menon, Claire Donohoe, Narayanasamy Ravi, John V. Reynolds, Stephen G. Maher, Niamh Lynam"Lennon, Breandán N. Kennedy, Adriele Prina"Mello, Jacintha O"Sullivan, Targeting Radiation Resistance in Oesophageal Adenocarcinoma with Pyrazinib-Functionalised Gold Nanoparticles, Cancers, 16, (23), 2024, p4007 - 4007, p4007-4007
Maitiú Ó Murchú, Xuehua Lin, Melissa Anne Tutty, Christina Cahill, Ian S. Miller, Lasse Jensen, Adriele Prina"Mello, Niamh Lynam"Lennon, Stephen G. Maher, Helena Kelly, Jacintha O"Sullivan, Enhancing cancer radiotherapy efficacy using NanOx, a novel oxygenating perfluorocarbon nanoemulsion that reverses tumour hypoxia., Cancer Letters, 2024, p217406 - 217406, p217406-217406
Husvinee Sundaramurthi, Valentina Tonelotto, Kieran Wynne, Fiona O"Connell, Eve O"Reilly, Marcel Costa-García, Csenger Kovácsházi, Ágnes Kittel, Simone Marcone, Alfonso Blanco, Éva Pállinger, Szabolcs Hambalkó, J.M. Piulats Rodriguez, Péter Ferdinandy, Jacintha O"Sullivan, David Matallanas, Lasse D. Jensen, Zoltán Giricz, Breandán N. Kennedy, Ergolide mediates anti-cancer effects on metastatic uveal melanoma cells and modulates their cellular and extracellular vesicle proteomes, Open Research Europe, 3, 2023, p88 - 88, p88-88
Croí E. Buckley, Xiaofei Yin, Sebastian Meltzer, Anne Hansen Ree, Kathrine Røe Redalen, Lorraine Brennan, Jacintha O"Sullivan, Niamh Lynam"Lennon, Energy Metabolism Is Altered in Radioresistant Rectal Cancer, International Journal of Molecular Sciences, 24, (8), 2023, p7082 - 7082, p7082-7082
Moran J, Mylod E, Kane LE, Marion C, Keenan E, Mekhaeil M, Lysaght J, Dev KK, O'Sullivan J, Conroy MJ., Investigating the Effects of Olaparib on the Susceptibility of Glioblastoma Multiforme Tumour Cells to Natural Killer Cell-Mediated Responses, Pharmaceutics, 2023
Oâ Connell, F. and Mylod, E. and Donlon, N.E. and Heeran, A.B. and Butler, C. and Bhardwaj, A. and Ramjit, S. and Durand, M. and Lambe, G. and Tansey, P. and Welartne, I. and Sheahan, K.P. and Yin, X. and Donohoe, C.L. and Ravi, N. and Dunne, M.R. and Brennan, L. and Reynolds, J.V. and Roche, H.M. and Oâ Sullivan, J., Energy Metabolism, Metabolite, and Inflammatory Profiles in Human Ex Vivo Adipose Tissue Are Influenced by Obesity Status, Metabolic Dysfunction, and Treatment Regimes in Patients with Oesophageal Adenocarcinoma, Cancers, 15, (6), 2023
Sarah Elizabeth Lochrin, Oana Deac, Jacintha O"Sullivan, Moya Cunningham, Narayanasamy Ravi, Claire Donohoe, Grainne M. O"Kane, John V. Reynolds, Maeve A. Lowery, Clinicopathologic features of early-onset (EO) esophageal and gastric cancers., Journal of Clinical Oncology, 41, (4_suppl), 2023, p472 - 472, p472-472
Buckley, C.E. and Oâ Brien, R.M. and Nugent, T.S. and Donlon, N.E. and Oâ Connell, F. and Reynolds, J.V. and Hafeez, A. and Oâ RÃordáin, D.S. and Hannon, R.A. and Neary, P. and Kalbassi, R. and Mehigan, B.J. and McCormick, P.H. and Dunne, C. and Kelly, M.E. and Larkin, J.O. and Oâ Sullivan, J. and Lynam-Lennon, N., Metformin is a metabolic modulator and radiosensitiser in rectal cancer, Frontiers in Oncology, 13, (1216911), 2023
Kimberly A. Luddy, Jeffery West, Mark Robertson"Tessi, Bina Desai, Taylor M. Bursell, Sarah Barrett, Joel S. Brown, Jacintha O"Sullivan, Robert A. Gatenby, Laure Marignol, Alexander R.A. Anderson, Cliona O"Farrelly, Abstract 2858: Radiotherapy and NK cell-based immunotherapy: An evolutionary double-bind, Cancer Research, 83, (7_Supplement), 2023, p2858 - 2858, p2858-2858
Darragh O"Dowd, Jacintha O"Sullivan, Simone Marcone, Prognostic, Diagnostic and Predictive Biomarkers in the Barrett"s Oesophagus-Adenocarcinoma Disease Sequence, Cancers, 14, (14), 2022, p3427 - 3427, p3427-3427
R Corcoran, Finbarr O"Connell, Jacintha O"Sullivan, David Kevans, P078 Vedolizumab Treatment of ex-vivo Human Ulcerative Colitis (UC) Explants Results in Altered Inflammatory Protein Secretion Profiles, Journal of Crohn s and Colitis, 16, (Supplement_1), 2022, pi180 - i181, pi180-i181
J E A O'Connell, Finbarr O"Connell, Jacintha O"Sullivan, David Kevans, P102 Changes in serum immune protein profiles following vedolizumab therapy in Inflammatory Bowel Disease, Journal of Crohn s and Colitis, 16, (Supplement_1), 2022, pi198 - i199, pi198-i199
R Corcoran, Finbarr O"Connell, Jacintha O"Sullivan, David Kevans, P084 Secreted inflammatory protein profiles following treatment of ex-vivo human Ulcerative Colitis and Crohn"s Disease explants with licenced biologic therapies, Journal of Crohn s and Colitis, 16, (Supplement_1), 2022, pi184 - i184, pi184-i184
Brennan, L., Sadeghi, F., O'Neill, L., Guinan, E., Smyth, L. Sheill, G., Smyth, E., Doyle, S.L., Timon, C., Connolly, D., O'Sullivan, J., Reynolds, J.V., and Hussey, J., Telehealth Delivery of a Multi-Disciplinary Rehabilitation Programme for Upper Gastro-Intestinal Cancer: ReStOre@Home Feasibility Study, Cancers, 2022
Guo, N. and Minas, G. and Synowsky, S.A. and Dunne, M.R. and Ahmed, H. and McShane, R. and Bhardwaj, A. and Donlon, N.E. and Lorton, C. and O'Sullivan, J. and Reynolds, J.V. and Caie, P.D. and Shirran, S.L. and Lynch, A.G. and Stewart, A.J. and Arya, S., Identification of plasma proteins associated with oesophageal cancer chemotherapeutic treatment outcomes using SWATH-MS, Journal of Proteomics, 266, (104684), 2022
Naimimohasses S, O'Gorman P, Wright C, Ni Fhloinn D, Holden D, Conlon N, Monaghan A, Kennedy M, Gormley J, Beddy P, Finn SP, Lysaght J, O'Sullivan J, Dunne MR, Norris S, Moore JB., Differential Effects of Dietary versus Exercise Intervention on Intrahepatic MAIT Cells and Histological Features of NAFLD, Nutrients, 14, (11), 2022, p2198
Fiona O"Connell, Eimear Mylod, Ailsing B. Heeran, Noel E. Donlon, Maria Davern, Christine Butler, Anshul Bhardwaj, Claire L. Donohoe, Narayanasamy Ravi, John V. Renyolds, Margaret R. Dunne, Helen M. Roche, Jacintha O"Sullivan, Abstract 1990: Exploring the immune-metabolic mechanisms of adipose tissue in oesophageal adenocarcinoma, Cancer Research, 82, (12_Supplement), 2022, p1990 - 1990, p1990-1990
J E A O'Connell, Jayne Doherty, Amy M. Buckley, David Cormican, Cara Dunne, Karen Hartery, John O. Larkin, F MacCarthy, Paul McCormick, Susan McKiernan, Brian Mehigan, Cian Muldoon, Ciara Ryan, Jacintha O"Sullivan, David Kevans, Colonic oncostatin M expression evaluated by immunohistochemistry and infliximab therapy outcome in corticosteroid-refractory acute severe ulcerative colitis, Intestinal Research, 20, (3), 2022, p381 - 385, p381-385
Noel E. Donlon, Maria Davern, Andrew D. Sheppard, Fiona O'Connell, Margaret R. Dunne, Conall Hayes, Eimear Mylod, Sinead Ramjit, Hugo Temperley, Michael Mac Lean, Gillian Cotter, Anshul Bhardwaj, Christine Butler, Melissa J. Conroy, Jacintha O'Sullivan, Narayanasamy Ravi, Claire L. Donohoe, John V. Reynolds and Joanne Lysaght, The Impact of Esophageal Oncological Surgery on Perioperative Immune Function; Implications for Adjuvant Immune Checkpoint Inhibition, Frontiers in Immunology, 2022
R Corcoran, P. MacDonagh, Fiona O"Connell, Maria E. Morrissey, Margaret R. Dunne, Ruth Argue, Jacintha O"Sullivan, David Kevans, Association Between Ex Vivo Human Ulcerative Colitis Explant Protein Secretion Profiles and Disease Behaviour, Digestive Diseases and Sciences, 67, (12), 2022, p5540 - 5550, p5540-5550
Maryam Mukhtar, Niall Ashfield, "udmila Vodi"ková, Veronika Vymetalková, Miroslav Levý, Václav Liška, Jan Br"ha, Petra Bendová, Jacintha O"Sullivan, Glen Doherty, Kieran Sheahan, Bláthnaid Nolan, Pavel Vodi"ka, David J. Hughes, The Associations of Selenoprotein Genetic Variants with the Risks of Colorectal Adenoma and Colorectal Cancer: Case"Control Studies in Irish and Czech Populations, Nutrients, 14, (13), 2022, p2718 - 2718, p2718-2718
Bennett, A.E., O'Neill, L., Connolly, D., Guinan, E., Boland, L., Doyle, S., O'Sullivan, J., Reynolds, J.V., Hussey, J., Perspectives of Esophageal Cancer Survivors on Diagnosis, Treatment, and Recovery., Cancers, 13, (1), 2021, p1-12
E. Flis, G. Barber, C. Nulty, B. Keogh, P. McGuirk, A. Anand, J. O'Sullivan, M. Quante, E.M. Creagh. , Identification of TLR2 signalling mechanisms which Contribute to Barrett's and Oesophageal Adenocarcinoma Disease Progression, Cancers (Basel) , 13, (9), 2021, p2065 - 2081
Kennedy, S.A., Annett, S.L., Dunne, M.R., Boland, F., O'Neill, L.M., Guinan, E.M., Doyle, S.L., Foley, E.K., Elliott, J.A., Murphy, C.F., Bennett, A.E., Carey, M., Hillary, D., Robson, T., Reynolds, J.V., Hussey, J., O'Sullivan, J.N., Effect of the Rehabilitation Program, ReStOre, on Serum Biomarkers in a Randomized Control Trial of Esophagogastric Cancer Survivors, Frontiers in Oncology, 11, (669078), 2021, p1-11
G. Barber, A. Anand, K. Oficjalska, J.J. Phelan, A. B. Heeran, E. Flis, N. E. Clarke, J. A. Watson, J. Strangmann, B. Flood, H. O'Neill, D. O'Toole, F. MacCarthy, N. Ravi, J. V. Reynolds, E.W. Kay, M. Quante, J. O'Sullivan, E.M. Creagh., Characterizing caspase-1 involvement during esophageal disease progression. , Cancer Immunology Immunotherapy, 69, (12), 2020, p2635 - 2649
O'NEILL L., GUINAN E., DOYLE S., CONNOLLY D., O'SULLIVAN J., BENNETT A., SHEILL G., SEGURADO R., KNAPP P., FAIRMAN C., NORMAND C., GEOGHEGAN J., CONLON K., REYNOLDS JV., HUSSEY J., Rehabilitation strategies following oesophagogastric and hepatopancreaticobiliary cancer (ReStOre II): a protocol for a randomised controlled trial, BMC Cancer, 20, 2020, p1 - 20
O'Neill L., Guinan E., Doyle S., O'Connor L., Sheill G., Smyth E., Fairman C., Segurado R., Connolly D., O'Sullivan J., Reynolds JV., Hussey J, ReStOre@Home: Feasibility study of a virtually delivered 12-week multidisciplinary rehabilitation programme for survivors of upper gastrointestinal (UGI) cancer - study protocol, HRB Open Research, 2020
Cannon, A. and Clarke, N. and MacCarthy, F. and Dunne, C. and Kevans, D. and Mahmud, N. and Lysaght, J. and O'Sullivan, J., Effect of cigarette smoke extract on the intestinal microenvironment of ulcerative colitis tissue, JGH Open, 4, (6), 2020, p1191-1198
Azizah M. Malebari, Darren Fayne, Seema M. Nathwani, Fiona O'Connell, Sara Noorani, Brendan Twamley, Niamh M. O'Boyle, Jacintha O'Sullivan, Daniela M. Zisterer, Mary J. Meegan, Beta-lactams with antiproliferative and antiapoptotic activity in breast and chemoresistant colon cancer cells, European Journal of Medicinal Chemistry, 189, 2020, p112050-
Buckley AM, Dunne MR, Morrissey ME, Kennedy SA, Nolan A, Davern M, Foley EK, Clarke N, Lysaght J, Ravi N, O'Toole D, MacCarthy F, Reynolds JV, Kennedy BN, O'Sullivan J., Real-time metabolic profiling of oesophageal tumours reveals an altered metabolic phenotype to different oxygen tensions and to treatment with Pyrazinib., Scientific reports, 10, (1), 2020, p12105
Guinan, E.M., Bennett, A.E., Doyle, S.L., O'Neill, L, Gannon, J., Foley, G., Elliott, J.A., O'Sullivan, J., Reynolds, J.V., & Hussey, J., Measuring the impact of oesophagectomy on physical functioning and physical activity participation: a prospective study, BMC Cancer, 19, (682), 2019
O'Neill L., Knapp P., Doyle SL., Guinan E., Parker A.,Segurado R., Connolly D., O'Sullivan J., Reynolds JV., Hussey J, 'Patient and family co-developed participant information to improve recruitment rates, retention, and patient understanding in the Rehabilitation Strategies Following Oesophago-gastric and Hepatopancreaticobiliary Cancer (ReStOre II) trial: Protocol for a study within a trial (SWAT) [version 1; peer review: awaiting peer review]', 2019, -
Melo, Ashanty M., O'Brien, Aisling M., Phelan, James J., Kennedy, Susan A., Wood, Nicole A. W., Veerapen, Natacha, Besra, Gurdyal S., Clarke, Niamh E., Foley, Emma K., Ravi, Akshaya, MacCarthy, Finbar, O'Toole, Dermot, Ravi, Narayamasami, Reynolds, John V., Conroy, Melissa J., Hogan, Andrew E., O'Sullivan, Jacintha, Dunne, Margaret R., Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma, Frontiers in Immunology, 10, 2019
Butler, C.T. and Kennedy, S.A. and Buckley, A. and Doyle, R. and Conroy, E. and Gallagher, W.M. and O'Sullivan, J. and Kennedy, B.N., 1,4-dihydroxy quininib attenuates growth of colorectal cancer cells and xenografts and regulates the TIE-2 signaling pathway in patient tumours, Oncotarget, 10, (38), 2019, p3725-3744
Buckley AM, Dunne MR, Lynam-Lennon N, Kennedy SA, Cannon A, Reynolds AL, Maher SG, Reynolds JV, Kennedy BN, O'Sullivan J., Pyrazinib (P3), [(E)-2-(2-Pyrazin-2-yl-vinyl)-phenol], a small molecule pyrazine compound enhances radiosensitivity in oesophageal adenocarcinoma., Cancer letters, 447, 2019, p115-129
Guinan, E.M., Doyle, S.L., Bennett, A.E., O'Neill, L, Gannon, J., Elliott, J.A., O'Sullivan, J., Reynolds, J.V., & Hussey, J., Sarcopenia during neoadjuvant therapy for oesophageal cancer: characterising the impact on muscle strength and physical performance, Supportive Care in Cancer, 26, (5), 2018, p1569 - 1576
Bennett, A.E., O'Neill, L., Connolly, D., Guinan, E.M., Boland, L., Doyle, S.L., O'Sullivan, J., Reynolds, J.V., & Hussey, J., Patient experiences of a physiotherapy-led multidisciplinary rehabilitative intervention after successful treatment for oesophago-gastric cancer, Supportive Care in Cancer, 26, (8), 2018, p2615 - 2623
Buckley AM, Lynam-Lennon N, Kennedy SA, Dunne MR, Aird JJ, Foley EK, Clarke N, Ravi N, O'Toole D, Reynolds JV, Kennedy BN, O'Sullivan J., Leukaemia inhibitory factor is associated with treatment resistance in oesophageal adenocarcinoma., Oncotarget, 9, (72), 2018, p33634-33647
James J. Phelan, Finbar MacCarthy, Dermot O'Toole, Narayanasamy Ravi, John V. Reynolds and Jacintha O'Sullivan, The Mitochondrial Genes BAK1, FIS1 and SFN are Linked with Alterations in Mitochondrial Membrane Potential in Barrett's Esophagus, International Journal of Molecular Sciences, 19, (11), 2018
Sinead A. Noonan*, Maria E. Morrissey*, Petra Martin, Monika Biniecka, Shane Ó'Meachair, Aoife Maguire, Miriam Tosetto, Blathnaid Nolan, John Hyland, Kieran Sheahan, Diarmuid O'Donoghue, Hugh Mulcahy, David Fennelly, Jacintha O'Sullivan, Tumour vasculature immaturity, oxidative damage and systemic inflammation stratify survival of colorectal cancer patients on bevacizumab treatment, Oncotarget, 9, 2018, p10536 - 10548
O'Neill, L.M., Guinan, E., Doyle, S.L., Bennett, A.E., Murphy, C., Elliott, J.A., O'Sullivan, J., Reynolds, J.V., Hussey, J., The RESTORE Randomized Controlled Trial: Impact of a multidisciplinary rehabilitative program on cardiorespiratory fitness in esophagogastric cancer survivorship, Annals of Surgery, 268, (5), 2018, p747 - 755
Donohoe C.L, Lysaght J, O'Sullivan J, Reynolds J.V, Emerging Concepts Linking Obesity with the Hallmarks of Cancer, Trends in Endocrinology and Metabolism, 28, (1), 2017, p46 - 62
Butler C.T, Reynolds A.L, Tosetto M, Dillon E.T, Guiry P.J, Cagney G, O'Sullivan J, Kennedy B.N, A quininib analogue and cysteinyl leukotriene receptor antagonist inhibits vascular endothelial growth factor (VEGF)-independent angiogenesis and exerts an additive antiangiogenic response with bevacizumab, Journal of Biological Chemistry, 292, (9), 2017, p3552 - 3567
Prichard David O, Byrne Anne Marie, Murphy James O, Reynolds John V, O'Sullivan Jacintha, Feighery Ronan, Doyle Brendan, Eldin Osama Sharaf, Finn Stephen P, Maguire Aoife, Duff Deirdre, Kelleher Dermot P, Long Aideen, Deoxycholic acid promotes development of gastroesophageal reflux disease and Barrett's oesophagus by modulating integrin-αv trafficking , Journal of cellular and molecular medicine , 21 , (12 ), 2017, p3612 - 3625
Linda O'Neill, Emer Guinan, Suzanne L Doyle, Jessie A. Elliott, Jacintha O'Sullivan, John V. Reynolds, Juliette Hussey, Rehabilitation Strategies following esophageal cancer (the ReStOre trial): a feasibility study, Diseases of the Esophagus, 30, (5), 2017, p1 - 8
Phelan JJ, Feighery R, Eldin OS, Meachair SÓ, Cannon A, Byrne R, MacCarthy F, O'Toole D, Reynolds JV, O'Sullivan J, Examining the connectivity between different cellular processes in the Barrett tissue microenvironment., Cancer letters, 371, (2), 2016, p334-46
Kavanagh ME, Conroy MJ, Clarke NE, Gilmartin NT, O'Sullivan KE, Feighery R, MacCarthy F, O'Toole D, Ravi N, Reynolds JV, O'Sullivan J, Lysaght J, Impact of the inflammatory microenvironment on T-cell phenotype in the progression from reflux oesophagitis to Barrett oesophagus and oesophageal adenocarcinoma., Cancer letters, 370, (1), 2016, p117-24
Clare T. Butler, Breandán N. Kennedy, William M. Gallagher, Jacintha O"Sullivan, Abstract 3058: Phenotype-based discovery and development of novel therapies for the treatment of colorectal cancer, Cancer Research, 76, (14_Supplement), 2016, p3058 - 3058, p3058-3058
Lorraine Burke, Clare T. Butler, Adrian Murphy, Bruce Moran, William M. Gallagher, Jacintha O"Sullivan, Breandán N. Kennedy, Evaluation of Cysteinyl Leukotriene Signaling as a Therapeutic Target for Colorectal Cancer, Frontiers in Cell and Developmental Biology, 4, 2016
Lynam-Lennon N., Bibby B., Mongan A., Marignol L., Paxton C., Geiersbach K., Geiersbach K., Bronner M., Bronner M., O"Sullivan J., Reynolds J., Maher S., Maher S., Low MiR-187 expression promotes resistance to chemoradiation therapy in vitro and correlates with treatment failure in patients with esophageal adenocarcinoma, Molecular Medicine, 22, 2016, p388-397
Dowling C, Phelan J, Cathcart M, Mehigan B, McCormick P, Dalton T, Coffey C, Newton A, O'Sullivan J and Kiely P., Protein Kinase C Beta II suppresses colorectal cancer by regulating IGF-1 mediated cell survival, Oncotarget, 7, 2016, p20919-20933
Moriarity A, O'Sullivan J, Kennedy J, Mehigan B, McCormick P, Current targeted therapies in the treatment of advanced colorectal cancer: A review, Therapeutic Advances in Medical Oncology, 8, (4), 2016, p276 - 293
Catríona M. Dowling, James J. Phelan, Julia A. Callender, Mary Clare Cathcart, Brian Mehigan, Paul McCormick, Tara Dalton, John Calvin Coffey, Alexandra C. Newton, Jacintha O"Sullivan, Patrick A. Kiely, Abstract 1888: Protein kinase C beta II suppresses colorectal cancer by regulating IGF1 mediated cell survival, Cancer Research, 76, (14_Supplement), 2016, p1888 - 1888, p1888-1888
Biniecka M, Canavan M, McGarry T, Gao W, McCormick J, Cregan S, Gallagher L, Smith T, Phelan JJ, Ryan J, O'Sullivan J, Ng CT, Veale DJ, Fearon U, Dysregulated bioenergetics: a key regulator of joint inflammation., 75, (12), 2016, p2192-2200
O'Farrell N.J, Feighery R, Picardo S.L, Lynam-Lennon N, Biniecka M, McGarrigle S.A, Phelan J.J, MacCarthy F, O'Toole D, Fox E.J, Ravi N, Reynolds J.V, O'Sullivan J, Changes in mitochondrial stability during the progression of the Barrett's esophagus disease sequence, BMC Cancer, 16, (1), 2016, p497-
Murphy A.G, Casey R, Maguire A, Tosetto M, Butler C.T, Conroy E, Reynolds A.L, Sheahan K, O'Donoghue D, Gallagher W.M, Fennelly D, Kennedy B.N, O'Sullivan J, Preclinical validation of the small molecule drug quininib as a novel therapeutic for colorectal cancer, Scientific Reports, 6, 2016
Grainne M. O"Kane, Sarah A. McGarrigle, Nadia Rehill, Michael Farrell, Jacintha O"Sullivan, Cian Muldoon, Padraic Mac Mathúna, Desmond N. Carney, David Gallagher, Levels of oxidative stress and telomeres in Lynch syndrome-associated malignancies., Journal of Clinical Oncology, 34, (4_suppl), 2016, p582 - 582, p582-582
Picardo SL, O'Brien MP, Feighery R, O'Toole D, Ravi N, O'Farrell NJ, O'Sullivan JN, Reynolds JV, A Barrett's esophagus registry of over 1000 patients from a specialist center highlights greater risk of progression than population-based registries and high risk of low grade dysplasia., Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E, 28, (2), 2015, p121-126
Catríona M. Dowling, James J. Phelan, Mary Clare Cathcart, Brian Mehigan, Paul McCormick, Tara Dalton, John Calvin Coffey, Jacintha O"Sullivan, Patrick A. Kiely, Abstract 2136: Correlating the expression of protein kinase C isozymes with the transformed phenotype in colorectal cancer, Cancer Research, 75, (15_Supplement), 2015, p2136 - 2136, p2136-2136
James J. Phelan, Ciara O"Hanlon, John V. Reynolds, Jacintha O"Sullivan, The Role of Energy Metabolism in Driving Disease Progression in Inflammatory, Hypoxic and Angiogenic Microenvironments, Gastro - Open Journal, 1, (2), 2015, p44 - 58, p44-58
Clare T. Butler, Adrian Murphy, William M. Gallagher, Jacintha O"Sullivan, Breandán N. Kennedy, Abstract 1383: Phenotype-based development of novel therapies for the treatment of colorectal cancer, Cancer Research, 75, (15_Supplement), 2015, p1383 - 1383, p1383-1383
Karolina Weiner"Gorzel, Eugene Dempsey, Ma"gorzata Milewska, Aloysius McGoldrick, Valerie Toh, Aoibheann Walsh, Sinéad Lindsay, Luke Gubbins, Aoife Cannon, Daniel Sharpe, Jacintha O"Sullivan, Madeline Murphy, Stephen F. Madden, Malcolm R. Kell, Amanda McCann, Fiona Furlong, Resistance to chemotherapy in ovarian cancer is miRrored by the microRNA miR-433-dependent dysregulation of the cell cycle., 2015
El-Mashed S., O'Donovan T., Kay E., Abdallah A., Cathcart M., O'Sullivan J., O'Grady A., Reynolds J., O'Reilly S., O'Sullivan G., McKenna S., LC3B globular structures correlate with survival in esophageal adenocarcinoma, BMC Cancer, 15, (1), 2015, p582-
Weiner-Gorzel K, Dempsey E, Milewska M, McGoldrick A, Toh V, Walsh A, Lindsay S, Gubbins L, Cannon A, Sharpe D, O'Sullivan J, Murphy M, Madden SF, Kell M, McCann A, Furlong F, Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells., Cancer medicine, 4, (5), 2015, p745-58
Phelan JJ, O'Hanlon C, Reynolds JV and O'Sullivan J, The role of energy metabolism in driving disease progression in inflammatory, hypoxic and angiogenic environments, Gastro., 1, (2), 2015, p44 - 58
Palles C, Chegwidden L, Li X, Findlay JM, Farnham G, Castro Giner F, Peppelenbosch MP, Kovac M, Adams CL, Prenen H, Briggs S, Harrison R, Sanders S, MacDonald D, Haigh C, Tucker A, Love S, Nanji M, deCaestecker J, Ferry D, Rathbone B, Hapeshi J, Barr H, Moayyedi P, Watson P, Zietek B, Maroo N, Gay L, Underwood T, Boulter L, McMurtry H, Monk D, Patel P, Ragunath K, Al Dulaimi D, Murray I, Koss K, Veitch A, Trudgill N, Nwokolo C, Rembacken B, Atherfold P, Green E, Ang Y, Kuipers EJ, Chow W, Paterson S, Kadri S, Beales I, Grimley C, Mullins P, Beckett C, Farrant M, Dixon A, Kelly S, Johnson M, Wajed S, Dhar A, Sawyer E, Roylance R, Onstad L, Gammon MD, Corley DA, Shaheen NJ, Bird NC, Hardie LJ, Reid BJ, Ye W, Liu G, Romero Y, Bernstein L, Wu AH, Casson AG, Fitzgerald R, Whiteman DC, Risch HA, Levine DM, Vaughan TL, Verhaar AP, van den Brande J, Toxopeus EL, Spaander MC, Wijnhoven BP, van der Laan LJ, Krishnadath K, Wijmenga C, Trynka G, McManus R, Reynolds JV, O'Sullivan J, MacMathuna P, McGarrigle SA, Kelleher D, Vermeire S, Cleynen I, Bisschops R, Tomlinson I, Jankowski J, Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett's Esophagus., Gastroenterology, 148, (2), 2015, p367-78
O'Sullivan KE, Reynolds JV, O'Hanlon C, O'Sullivan JN, Lysaght J, Could signal transducer and activator of transcription 3 be a therapeutic target in obesity-related gastrointestinal malignancy?, Journal of gastrointestinal cancer, 45, (1), 2014, p1-11
O'Sullivan KE, Phelan JJ, O'Hanlon C, Lysaght J, O'Sullivan JN, Reynolds JV., The role of inflammation in cancer of the esophagus., Expert Reviews Gastroenterology Hepatology, 8, (7), 2014, p749 - 760
Martin P, Noonan S, Mullen MP, Scaife C, Tosetto M, Nolan B, Wynne K, Hyland J, Sheahan K, Elia G, O'Donoghue D, Fennelly D, O'Sullivan J, Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer., BMC cancer, 14, 2014, p887
Sheridan, J., Walsh, P., Kevans, D., (...), Mulcahy, H., Doherty, G. , Determinants of short- and long-term survival from colorectal cancer in very elderly patients, Journal of Geriatric Oncology , 5, (4), 2014, p376-83
Sarah A. McGarrigle, Emer Guinan, Juliette Hussey, Jacintha O"Sullivan, Michael J. Kennedy, David Gallagher, Elizabeth Connolly, Prospective evaluation of the potential to reduce breast cancer risk, through lifestyle modifications in BRCA-mutation carriers., Journal of Clinical Oncology, 32, (15_suppl), 2014, pe12506 - e12506, pe12506-e12506
Kavanagh, M.E., O'Sullivan, K.E., O'Hanlon, C., (...), Lysaght, J., Reynolds, J.V., The esophagitis to adenocarcinoma sequence; the role of inflammation, Cancer Letters, 345, (2), 2014, p182-189
Lynam-Lennon N, Connaughton R, Carr E, Mongan AM, O'Farrell NJ, Porter RK, Brennan L, Pidgeon GP, Lysaght J, Reynolds JV, O'Sullivan J, Excess visceral adiposity induces alterations in mitochondrial function and energy metabolism in esophageal adenocarcinoma., BMC cancer, 14, 2014, p907
Phelan JJ, MacCarthy F, Feighery R, O'Farrell NJ, Lynam-Lennon N, Doyle B, O'Toole D, Ravi N, Reynolds JV, O'Sullivan J, Differential expression of mitochondrial energy metabolism profiles across the metaplasia-dysplasia-adenocarcinoma disease sequence in Barrett's oesophagus., Cancer letters, 354, (1), 2014, p122-31
Lynam-Lennon N, Maher SG, Maguire A, Phelan J, Muldoon C, Reynolds JV, O'Sullivan J, Altered mitochondrial function and energy metabolism is associated with a radioresistant phenotype in oesophageal adenocarcinoma., PloS one, 9, (6), 2014, pe100738
O'Toole A, Michielsen AJ, Nolan B, Tosetto M, Sheahan K, Mulcahy HE, Winter DC, Hyland JM, O'Connell PR, Fennelly D, O'Donoghue D, O'Sullivan J, Doherty GA, Ryan EJ, Tumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressive., British journal of cancer, 111, (5), 2014, p927-32
Suzanne Slattery, Jillian P. Casey, Niamh Lynam"Lennon, Paul Gettigan, Jacintha O"Sullivan, Michael Mc Dermott, Karina Forde, Ina Knerr, Eileen P. Treacy, Ardeshir A. Monavari, Joanne Hughes, B. Bourke, Sean Ennis, Sally Ann Lynch, Melanie Cotter, Ellen Crushell, G86(P) Clinical Phenotype associated with recessive mutations in LARS gene, Archives of Disease in Childhood, 99, (Suppl 1), 2014, pA36 - A37, pA36-A37
Guinan, EM, Hussey, J, McGarrigle, SA, Healy, LA, O'Sullivan, JN, Bennett, K, Connolly, EM, A prospective investigation of predictive and modifiable risk factors for breast cancer in unaffected BRCA1 and BRCA2 gene carriers, BMC CANCER, 13, 2013, p138-
Mary"Clare Cathcart, Jacintha O"Sullivan, Breandán N. Kennedy, John V. Reynolds, Graham P. Pidgeon, Abstract 5087: Thromboxane synthase and thromboxane receptor targeting have anti-angiogenic efficacy in-vivo and reduce angiogenic secretions from human colorectal tumor explants ex-vivo., Cancer Research, 73, (8_Supplement), 2013, p5087 - 5087, p5087-5087
Sheridan, J. Tosetto, M. Gorman, J. O'Donoghue, D. Sheahan, K. Hyland, J. Mulcahy, H. Gibbons, D. O'Sullivan, J., Effects of radiation on levels of DNA damage in normal non-adjacent mucosa from colorectal cancer cases, Journal of Gastrointestinal Cancer, 44, (1), 2013, p41 - 45
Breandán N. Kennedy, Yolanda Álvarez, Miriam Tosetto, Temitope Sasore, Claire Kilty, Alan W. Stitt, Jacintha O"Sullivan, Alison Reynolds, Chemical Screens in Zebrafish Identify Novel Inhibitors of Retinal Neovascularisation in Mouse, Investigative Ophthalmology & Visual Science, 54, (15), 2013, p4617 - 4617, p4617-4617
Niamh Lynam"Lennon, Stephen G. Maher, John V. Reynolds, Jacintha O"Sullivan, Abstract 1592: Mitochondrial dysfunction and radioresistance in esophageal cancer., Cancer Research, 73, (8_Supplement), 2013, p1592 - 1592, p1592-1592
Hu, J, Locasale, JW, Bielas, JH, O'Sullivan, J, Sheahan, K, Cantley, LC, Vander Heiden, MG, Vitkup, D, Heterogeneity of tumor-induced gene expression changes in the human metabolic network, NATURE BIOTECHNOLOGY, 31, (6), 2013, p522-U11
Doyle, B., Hagan, S., Al-Mulla, F., (...), O'Sullivan, J., Kolch, W. , Raf kinase inhibitor protein expression combined with peritoneal involvement and lymphovascular invasion predicts prognosis in Dukes' B colorectal cancer patients , Histopathology , 62, (3), 2013, p505-510
Brendan Doyle, Suzanne Hagan, Fahd Al"Mulla, Lucy Scott, Sharon Harden, James Paul, Hugh Mulcahy, Graeme I. Murray, Kieran Sheahan, Jacintha O"Sullivan, Walter Kölch, Raf kinase inhibitor protein expression combined with peritoneal involvement and lymphovascular invasion predicts prognosis in
Kevans D, Gorman S, Tosetto M, Sheahan K, O'Donoghue D, Mulcahy H and O'Sullivan J. , Clusterin and chemotherapy sensitivity under normoxic graded hypoxic conditions in colorectal cancer , Journal of Gastrointestinal Cancer , 43, (2), 2012, p305-313
Petra Martin, Sinéad Noonan, Bláthnaid Nolan, Caitríona Scaife, Giuliano Elia, Diarmuid P. O"Donoghue, D. Fennelly, Jacintha O"Sullivan, Characterization of serum proteome in patients with metastatic colorectal cancer responsive and nonresponsive to bevacizumab using 2 d-DIGE., Journal of Clinical Oncology, 30, (4_suppl), 2012, p484 - 484, p484-484
Mary-Clare Cathcart, Kenneth J. O'Byrne, John V. Reynolds, Jacintha O' Sullivan, Graham P. Pidgeon, COX-Derived prostanoid pathways in gastrointestinal cancer development and progression: Novel targets for prevention and intervention, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1825, (1), 2012, p49-63
Michielsen AJ, Ryan EJ, O'Sullivan JN, Dendritic cell inhibition correlates with survival of colorectal cancer patients on bevacizumab treatment., Oncoimmunology, 1, (8), 2012, p1445-1447
Canney, AL, Kevans, D, Wang, LM, Hyland, JMP, Mulcahy, HE, O'Donoghue, DP, O'Sullivan, J, Geraghty, R, Sheahan, K, Stage II colonic adenocarcinoma: a detailed study of pT4N0 with emphasis on peritoneal involvement and the role of tumour budding, HISTOPATHOLOGY, 61, (3), 2012, p488-496
Adrian Murphy, Rory Casey, D. Fennelly, Alison Reynolds, Miriam Tosetto, John Hyland, Kieran Sheahan, Diarmuid O"Donoghue, Hugh Mulcahy, Breandán N. Kennedy, Jacintha O"Sullivan, The effect of novel small molecule drugs in human explants across the disease sequence in colorectal cancer., Journal of Clinical Oncology, 30, (15_suppl), 2012, pe13570 - e13570, pe13570-e13570
Leonard C Harty, Monika Biniecka, Jacintha O'Sullivan, Edward Fox, Kevin Mulhall, Douglas J Veale, Ursula Fearon, Mitochondrial mutagenesis correlates with the local inflammatory environment in arthritis, Annals of the Rheumatic Diseases: The EULAR Journal, 71, (4), 2012, p582-588
Sinéad Noonan, Petra Martin, Aoife Maguire, Monika Biniecka, Miriam Tosetto, John Hyland, Kieran Sheahan, Diarmuid P. O"Donoghue, Hugh Mulcahy, D. Fennelly, Jacintha O"Sullivan, Correlation of markers of oxidative damage and circulating IL6 levels with survival following treatment with bevacizumab in metastatic colorectal cancer patients., Journal of Clinical Oncology, 30, (15_suppl), 2012, pe21024 - e21024, pe21024-e21024
Michielsen, AJ, Noonan, S, Martin, P, Tosetto, M, Marry, J, Biniecka, M, Maguire, AA, Hyland, JM, Sheahan, KD, O'Donoghue, DP, Mulcahy, HE, Fennelly, D, Ryan, EJ, O'Sullivan, JN, Inhibition of Dendritic Cell Maturation by the Tumor Microenvironment Correlates with the Survival of Colorectal Cancer Patients following Bevacizumab Treatment, MOLECULAR CANCER THERAPEUTICS, 11, (8), 2012, p1829-1837
Picardo SL, Maher SG, O'Sullivan JN, Reynolds JV, Barrett's to oesophageal cancer sequence: a model of inflammatory-driven upper gastrointestinal cancer., Digestive surgery, 29, (3), 2012, p251-60
Ericson, NG, Kulawiec, M, Vermulst, M, Sheahan, K, O'Sullivan, J, Salk, JJ, Bielas, JH, Decreased Mitochondrial DNA Mutagenesis in Human Colorectal Cancer, PLOS GENETICS, 8, (6), 2012, pe1002689-
Kirsha Naicker, Donal J. Brennan, Rut Klinger, Fredrik Pontén, Karin Jirström, Jacintha O"Sullivan, William M. Gallagher, Darran P. O"Connor, Abstract LB-444: SATB2 is a novel prognostic factor in colorectal cancer, Cancer Research, 72, (8_Supplement), 2012, pLB - 444, pLB-444
Kevans, D, Wang, LM, Sheahan, K, Hyland, J, O'Donoghue, D, Mulcahy, H, O'Sullivan, J, Epithelial-Mesenchymal Transition (EMT) Protein Expression in a Cohort of Stage II Colorectal Cancer Patients With Characterized Tumor Budding and Mismatch Repair Protein Status, INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 19, (6), 2011, p751-760
Kennedy, A., Teck Ng, C., Cheng Chang, T., (...), Fearon, U., Veale, D.J., Tumor necrosis factor blocking therapy alters joint inflammation and hypoxia, Arthritis and Rheumatism, 63, (4), 2011, p923-932
Kennedy RD, Bylesjo M, Kerr P, Davison T, Black JM, Kay EW, Holt RJ, Proutski V, Ahdesmaki M, Farztdinov V, Goffard N, Hey P, McDyer F, Mulligan K, Mussen J, O'Brien E, Oliver G, Walker SM, Mulligan JM, Wilson C, Winter A, O'Donoghue D, Mulcahy H, O'Sullivan J, Sheahan K, Hyland J, Dhir R, Bathe OF, Winqvist O, Manne U, Shanmugam C, Ramaswamy S, Leon EJ, Smith WI, McDermott U, Wilson RH, Longley D, Marshall J, Cummins R, Sargent DJ, Johnston PG, Harkin DP, Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29, (35), 2011, p4620-6
Sapetto-Rebow, B., McLoughlin, S.C., O'Shea, L.C., (...), Hensey, C., Kennedy, B.N. , Maternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a -/- mutants, BMC Developmental Biology , 11, 2011, p71-
Biniecka M, Fox E, Gao W, Ng CT, Veale DJ, Fearon U, O'Sullivan J, Hypoxia induces mitochondrial mutagenesis and dysfunction in inflammatory arthritis., Arthritis and rheumatism, 63, (8), 2011, p2172-82
Biniecka M, Kennedy A, Ng CT, Chang TC, Balogh E, Fox E, Veale DJ, Fearon U, O'Sullivan JN., Successful tumour necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxiainduced mitochondrial mutagenesis in inflammatory arthritis, Arthritis Research & Therapy , 13, (4), 2011, pR121
Biniecka, M., Fox, E., Gao, W., (...), Fearon, U., O'Sullivan, J., Hypoxia induces mitochondrial mutagenesis and dysfunction in inflammatory arthritis, Arthritis and Rheumatism, 63, (8), 2011, p2172-2182
Michielsen, AJ, Hogan, AE, Marry, J, Tosetto, M, Cox, F, Hyland, JM, Sheahan, KD, O'Donoghue, DP, Mulcahy, HE, Ryan, EJ, O'Sullivan, JN, Tumour Tissue Microenvironment Can Inhibit Dendritic Cell Maturation in Colorectal Cancer, PLOS ONE, 6, (11), 2011, pe27944-
Doherty G, Walsh P, Sheridan J, Kevans D, Keegan D, Nolan B, White A, McDermott E, Sheahan K, O'Shea D, Hyland J, O'Donoghue D, O'Sullivan J and Mulchay H. , Clinical and Pathological Factors associated with colorectal cancer at the Upper extreme of life, Journal of the American Geriatrics Society, 58, (4), 2010
Byrne A, Foran E, Sharma R, Davis A, Mahon C, O'Sullivan J, O'Donoghue D, Kelleher D, Long A. , Opposing effects of Deoxycholic and Ursodeoxycholic acid on Golgi Structure: implications for colon cancer progression., Carcinogenesis, 31, (4), 2010, p737-44
Young O, Crotty T, O'Connell R, O'Sullivan J and Curran A. , Levels of oxidative damage and lipid peroxidation in thyroid neoplasia. , Head Neck, 32, (6), 2010, p750-756
Biniecka M, Kennedy A, T Ng C, Fearon U, Douglas J Veale, O'Sullivan J. , Oxidative damage in synovial tissue is associated with in vivo hypoxic status in the arthritic joint, Annals of the Rheumatic Diseases, 69, (6), 2010
Adriana J. Michielsen, Jacintha O"Sullivan, Elizabeth J. Ryan, Recent Advances in the Development of Novel Therapeutics Targeting Dendritic Cells, Recent Patents on Endocrine Metabolic & Immune Drug Discovery, 4, (2), 2010, p146 - 152, p146-152
Byrne AM, Foran E, Sharma R, Davies A, Mahon C, O'Sullivan J, O'Donoghue D, Kelleher D, Long A, Bile acids modulate the Golgi membrane fission process via a protein kinase Ceta and protein kinase D-dependent pathway in colonic epithelial cells., Carcinogenesis, 31, (4), 2010, p737-744
Gorman S, Fox E, O'Donoghue D, Sheahan K, Hyland J, Mulcahy H, Loeb L and O'Sullivan J., Mitochondrial mutagenesis induced by tumour specific radiation bystander effects , Journal of Molecular Medicine, 88, (7), 2010, p701 - 8
Bronner M, Skacel M, Crispin D, Hoff P, Emond M, Lai L, Tubbs R, O'Sullivan J, Rabinovitch P and Brentnall T., Array-based comparative genomic hybridization in ulcerative colitis neoplasia: single non dysplastic biopsies distinguish progressors from non progressors, Modern Pathology, 23, (12), 2010
Howe O, O' Sullivan J, Nolan B, Vaughan J, Clarke C, Gorman S, McClean B, Lyng F, Do radiation-induced bystander effects correlate to the intrinsic radiosensitivity of individuals and have clinical significance? , Radiation Research, 171, 2009, p521-529.
Sullivan S, Tosetto M, Kevans D, Coss A, Wang L, O'Donoghue D, Hyland J, Fennelly D, Sheahan K, Mulcahy H & O'Sullivan J. , Localization of a nuclear Cathepsin L and its association with disease progression and poor outcome in colorectal cancer. , Int J Cancer, 1;125, (1), 2009, p54-61
Kevans D, Foley J, Tenniswood M, Sheahan K, Hyland J, O'Donoghue D, Mulchay H and O'Sullivan J. , High clusterin expression correlates with a poor outcome in Stage II T3NO colorectal cancer. , Cancer Epidemiology Biomarkers and Prevention, 18, (2), 2009, p393-399
Watson J, Watson C, McCrohan A, Woodfine K, Tosetto M, McDaid J, Gallagher E, Betts D, Baugh J, O'Sullivan J, Murrell A, Watson W and McCann A. , Generation of an epigenetic signature by chronic hypoxia in prostate cells., Hum Mol Genet., 1;18, (19), 2009, p3594-604.
Coss A, Tosetto M, Fox E, Sapetto-Rebow B, Gorman S, Kennedy B, Lloyd, Hyland J, O'Donoghue D, Sheahan K, Leahy D, Mulcahy H, O'Sullivan J. , Increased Topoisomerase IIα Expression in Colorectal Cancer is Associated with Pathologically Aggressive Disease and Leads to Chemotherapy Resistance via Inhibition of Apoptosis. , Cancer Lett., 276, (2), 2009, p228-238
Coss, A, Tosetto, M, Fox, EJ, Sapetto-Rebow, B, Gorman, S, Kennedy, BN, Lloyd, AT, Hyland, JM, O'Donoghue, DP, Sheahan, K, Leahy, DT, Mulcahy, HE, O'Sullivan, JN, Increased topoisomerase IIalpha expression in colorectal cancer is associated with advanced disease and chemotherapeutic resistance via inhibition of apoptosis., Cancer letters, 276, (2), 2009
Prencipe M, Fitzpatrick P, Gorman S, Tosetto M, Furlong F, Harrison M, O'Sullivan J, McCann A. , Cellular senescence induced by abberant MAD2 levels impacts on paclitaxel responsiveness in vitro. , Br J Cancer. , 1:101, (11), 2009, p1900-8
Wang L, Kevans D, Mulcahy H, O'Sullivan J, Hyland J, O'Donoghue D and Sheahan K. , Tumour budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer. , The American Journal of Surgical Pathology, 33, (1), 2009, p134-141
Gorman S, Tosetto M, Lyng F, Howe O, Sheahan K, O'Donoghue D, Hyland J, Mulcahy H and O'Sullivan J. , Radiation and chemotherapy bystander effects induce early genomic instability events: telomere shortening and bridge formation coupled with mitochondrial dysfunction. , Mutat Res. , 2, (669), 2009, p1-2
Sheridan J, Wang L, Tosetto M, Dave Kevans, Hyland J, Sheahan K, O'Donoghue D, Mulcahy H & O'Sullivan J. , High levels of 8-Hydroxyguanine, a marker of oxidative DNA Damage predicts overall survival in sporadic colorectal cancer, Br J Cancer., 100, (2), 2009, p381-388.
O'Sullivan J, Sheridan J, Mulcahy H, Tenniswood M, Morrissey C, The effect of green tea on oxidative damage and tumour formation in Lobund-Wistar rats., European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 17, (6), 2008, p489-501
Bronner MP, O'Sullivan JN, Rabinovitch PS, Crispin DA, Chen L, Emond MJ, Rubin CE, Brentnall TA, Genomic biomarkers to improve ulcerative colitis neoplasia surveillance., The American journal of pathology, 173, (6), 2008, p1853-60
Lynch, L, O'Donoghue, D, Dean, J, O'Sullivan, J, O'Farrelly, C, Golden-Mason, L, Detection and characterization of hemopoietic stem cells in the adult human small intestine., Journal of immunology (Baltimore, Md. : 1950), 176, (9), 2006, p5199-204
O'Sullivan J, Risques RA, Mandelson MT, Chen L, Brentnall TA, Bronner MP, Macmillan MP, Feng Z, Siebert JR, Potter JD, Rabinovitch PS, Telomere length in the colon declines with age: a relation to colorectal cancer?, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 15, (3), 2006, p573-7
O'Sullivan JN, Finley JC, Risques RA, Shen WT, Gollahon KA, Rabinovitch PS, Quantitative fluorescence in situ hybridization (QFISH) of telomere lengths in tissue and cells., Current protocols in cytometry / editorial board, J. Paul Robinson, managing editor ... [et al.], Chapter 12, 2005, pUnit 12.6
O'Sullivan JN, Finley JC, Risques RA, Shen WT, Gollahon KA, Moskovitz AH, Gryaznov S, Harley CB, Rabinovitch PS, Telomere length assessment in tissue sections by quantitative FISH: image analysis algorithms., Cytometry. Part A : the journal of the International Society for Analytical Cytology, 58, (2), 2004, p120-31
Zierau O, O'Sullivan J, Morrissey C, McDonald D, Wünsche W, Schneider MR, Tenniswood MP, Vollmer G, Tamoxifen exerts agonistic effects on clusterin and complement C3 gene expression in RUCA-I primary xenografts and metastases but not normal uterus., Endocrine-related cancer, 11, (4), 2004, p823-30
O'Sullivan J, Whyte L, Drake J, Tenniswood M, Alterations in the post-translational modification and intracellular trafficking of clusterin in MCF-7 cells during apoptosis., Cell death and differentiation, 10, (8), 2003, p914-27
Morrissey C, Buser A, Scolaro J, O'Sullivan J, Moquin A, Tenniswood M, Changes in hormone sensitivity in the ventral prostate of aging Sprague-Dawley rats., Journal of andrology, 23, (3), 2002, p341-51
O'Sullivan JN, Bronner MP, Brentnall TA, Finley JC, Shen WT, Emerson S, Emond MJ, Gollahon KA, Moskovitz AH, Crispin DA, Potter JD, Rabinovitch PS, Chromosomal instability in ulcerative colitis is related to telomere shortening., Nature genetics, 32, (2), 2002, p280-4
Tenniswood M, Wang Z, Lakins J, Morrissey C, O'Sullivan J, Tang H, Clusterin in the male reproductive tract., Journal of andrology, 19, (5), 1998, p508-16
Lakins J, Bennett SA, Chen JH, Arnold JM, Morrissey C, Wong P, O'Sullivan J, Tenniswood M, Clusterin biogenesis is altered during apoptosis in the regressing rat ventral prostate., The Journal of biological chemistry, 273, (43), 1998, p27887-95
Non-Peer-Reviewed Publications
Alina Qaisar, Jacintha O'Sullivan, Niamh M. O'Boyle, P22: Synthesis and Physicochemical Properties of Amino Acid Prodrugs of the Radiosensitser Pyrazinib, 30th Annual GP2A Medicinal Chemistry Conference, Dublin, 24-26 August 2022, 2022